STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program

The White House has used the program to reward companies that help its political goals.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

The White House has used the program to reward companies that help its political goals.
Source
Stat News
Opens original article in a new tab

Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.

(MedPage Today) -- A major change to how the popular President's Emergency Plan for AIDS Relief (PEPFAR) program operates took effect on June 1, which experts warn will result in a massive decline in the U.S.'s public health presence abroad. Historically...

(MedPage Today) -- People who consumed the most ultraprocessed foods -- sugar-sweetened drinks, packaged snacks, or processed meats, for example -- were more likely to develop a composite outcome of dementia or cognitive impairment compared...

(MedPage Today) -- Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin's patents for its anti-hypertriglyceridemia drug icosapent ethyl (Vascepa), the Supreme Court...